It allows users to generate cell lines suitable for clinical development without their own starter cells, vectors or prior experience in the field.
With this expansion, the Grand Island site provides redundant capacity to support global supply of media and further extends the site’s capabilities to produce the high-quality technology and materials needed for the development and commercial manufacturing of vaccines and biologic therapies
Sam Samad will be departing Illumina on July 8, 2022, after serving as CFO for more than five years.
The $44 million facility is part of Thermo Fisher's $650 million multi-year investment, announced last year, to help ensure flexible, scalable and reliable bioprocessing production capacity exists for critical materials used in developing new and existing biologics and vaccines, including for COVID-19
Breakthrough formulation helps reduce the risk of exposure using a non-hazardous formulation and leakproof format during transport and processing
New instrument helps maximize lab productivity and extends FTIR to large, heavy samples
The US $ 192.5 mn US government contract will help fund the centre of excellence to boost the domestic supply of critically needed laboratory plastics
Thermo Fisher Scientific expands diagnostics portfolio to support full qPCR assay development and testing workflow
The Thermo Scientific Orbitrap Exploris MX enables customer success by combining high-quality data with operational simplicity
Subscribe To Our Newsletter & Stay Updated
